Cleared Traditional

K172717 - Automatic Tissue Processing Unit (FDA 510(k) Clearance)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K172717 · Bsl Co. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2018
Decision
259d
Days
Class 2
Risk

K172717 is an FDA 510(k) clearance for the Automatic Tissue Processing Unit. Classified as System, Suction, Lipoplasty (product code MUU), Class II - Special Controls.

Submitted by Bsl Co. (Gimhae-Si, KR). The FDA issued a Cleared decision on May 25, 2018 after a review of 259 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5040 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Bsl Co. devices

Submission Details

510(k) Number K172717 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 2017
Decision Date May 25, 2018
Days to Decision 259 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
145d slower than avg
Panel avg: 114d · This submission: 259d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUU System, Suction, Lipoplasty
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.5040
Definition See Federal Register Notice At 86 Fr 50887 “consolidation Of Devices That Process Autologous Human Cells, Tissues, And Cellular And Tissue-based Products At The Point Of Care To Produce A Therapeutic Article” (frn) (fda-2021-n-0881).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - MUU System, Suction, Lipoplasty

All 39
Devices cleared under the same product code (MUU) and FDA review panel - the closest regulatory comparables to K172717.
IntelliFat Disposable Adipose Tissue Harvesting and Transfer Kit, IntelliFat Body On Demand (BOD) Kit
K210528 · Millennium Medical Technologies Inc (Dba Cellmyx) · Mar 2022
SyntrFuge System
K203800 · Syntr Health Technologies, Inc. · Jul 2021
Smart Kit Basic, Smart Kit Pro
K202443 · Bsl Co., Ltd. · Mar 2021
REVOLVE ENVI 600 Advanced Adipose System
K193539 · Lifecell Corporation · May 2020
Dermapose Refresh
K193363 · Puregraft, LLC · Apr 2020